Tag Archives: Roche

Competition Commission of India pulls up Roche for anti-competitive practices

By Jyotsna Singh, Scroll | April 27, 2017 In a landmark order, the commission has initiated an investigation into the multinational pharmaceutical company’s activities. The Competition Commission of India has initiated an investigation into Swiss pharmaceutical giant Roche for unfair … Continue reading

Posted in Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer, Uncategorized | Tagged , , , | Leave a comment

CCI to investigate Swiss drugmaker Roche over breast cancer biosimilar

By Divya Rajagopal, The Economic Times | April 26, 2017 MUMBAI: The Competition Commission of India (CCI) will investigate Swiss drugmaker Roche over alleged attempts to block competitors from selling breast cancer drug Trastuzumab. The investigation has to be completed … Continue reading

Posted in Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer, Uncategorized | Tagged , , , , | Leave a comment

Indian competition commission issues a path breaking order on abuse of dominant position in pharmaceuticals

Rules Roche’s practices prima facie appear to be aimed at blocking affordable biosimilar trastuzumab – a cancer drug – in India In July 2016, Mylan Pharmaceuticals and Biocon Limited approached the Competition Commission of India regarding Roche’s anti-competitive conduct to … Continue reading

Posted in Anti competition, Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer | Tagged , , , , , | Leave a comment

Open letter to Roche and Merck from 83 organizations from Eastern Europe and Central Asia

Source: Community Advisory Board in Eastern Europe and Central Asia 83 organizations from Russia, Ukraine, Moldova, Georgia, Kyrgyzstan, Uzbekistan, Belarus, Lithuania, Estonia, Kazakhstan, Azerbaijan and Armenia signed an open letter addressed to manufacturers of Hepatitis C treatment with a request … Continue reading

Posted in Hepatitis C, Pricing, Right to Health | Tagged , , , , | Leave a comment

Big pharma mobilising patients in battle over drugs trials data

Source: Guardian Leaked memo from industry bodies reveals strategy to combat calls by regulators to force companies to publish results. Pharmaceutical industry has broadly resisted moves to share data from drugs trials more freely.

Posted in Clinical Trials, Generics, IP Rights | Tagged , , , , , , , , , , , | 1 Comment

Indian Court Limits Frivolous Drug Patenting, Clearing Path to Affordable Medicines

Source: Open Society Foundations Azadeh Momenghalibaf /January 3, 2013 Should pharmaceutical patents—which result in monopolistic pricing of medicines—apply to any new drug, regardless of how it was made and whether it offers anything new? This question was answered recently in … Continue reading

Posted in Evergreening, Hepatitis C | Tagged , , , | Leave a comment

India’s cancer burden: Why the govt’s CL ruling is so important

Source: First Post G Pramod Kumar Jan 15, 2013 Early last year, when the Union government allowed the production of Nexavar, a liver and kidney cancer drug, by an Indian company against the wishes of multinational pharma major Bayer, the … Continue reading

Posted in Campaign for Affordable Trastuzumab, Compulsory Licensing | Tagged , , , , | Leave a comment